Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome-Reference-Cited by-同舟云学术

Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome

Published:2018-06-23 Issue:12 Volume:77 Page:1838-1840
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Miao Miao,Hao Zhenye,Guo Yingying,Zhang Xiaoying,Zhang Shengxiao,Luo Jing,Zhao Xiangcong,Zhang Chen,Liu Xiaoqing,Wu Xiaoyan,Xu Dan,Zhao Jinfang,Lu Xuechun,Gao Chong,Li Xiaofeng

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

2. CD4 CD25 regulatory T cells are not impaired in patients with primary Sjögren's syndrome

3. Aspects of innate immunity in Sjögren's syndrome

4. Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis;Gullick;Clin Exp Immunol,2013

5. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis;Clinical Epidemiology and Global Health;2024-09

2. Interplay of Interferon signalling gene expression, DNA Methylation, and inflammatory cytokines in Sjögren’s Syndrome: a multi-omics Mendelian randomization study;2024-05-15

3. Regulation of Treg cells by cytokine signaling and co-stimulatory molecules;Frontiers in Immunology;2024-05-13

4. The efficacy and safety of short-term and low-dose IL-2 combined with tocilizumab to treat rheumatoid arthritis;Frontiers in Immunology;2024-04-22

5. Insufficient phosphorylation of STAT5 in Tregs inhibits the expression of BLIMP-1 but not IRF4, reduction the proportion of Tregs in pediatric aplastic anemia;Heliyon;2024-03